Australia News
Filter News
Found 6,567 articles
-
Q-Sera’s Innovative Blood Clotting Technology Granted Patent in US
8/20/2019
Medical device company Q-Sera Pty Ltd today announces that it has received a Notice of Allowance from the United States Patent & Trademark Office for the foundation patent of its innovative blood clotting technology for use in blood collection tubes.
-
Adherium and Summatix Announce Strategic Initiative to Enhance Hailie™ Solution’s Digital Platform Impact
8/20/2019
Leading respiratory medical device company Adherium has unveiled its new strategic data-based initiative with Summatix Pty Ltd, with the objective of enabling clinicians globally to enhance their care of patients with asthma and chronic obstructive pulmonary disease.
-
Osteoporosis is a disease where the bones become more porous and fragile, which dramatically increases the risk of bone fractures. It affects about 200 million people worldwide, is a progressive disease, and there are often are no symptoms until a fracture.
-
CORRECTING and REPLACING Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Cancer Stem Cell Effects of Proenzymes
8/13/2019
Propanc Discusses Next Steps for Promising Research Collaboration with University of Jaén and Granada to Further Optimize Quality, Safety and Performance of PRP
-
The research team found that some pancreatic tumors create a molecule that helps enable the spread of the cancer cells.
-
Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Cancer Stem Cell Effects of Proenzymes
8/12/2019
Propanc Discusses Next Steps for Promising Research Collaboration with University of Jaén and Granada to Further Optimize Quality, Safety and Performance of PRP
-
Medicines Development for Global Health Discloses Novo Nordisk as Purchaser of its Priority Review Voucher
8/9/2019
Today, in conjunction with its second quarter financial results, Novo Nordisk disclosed that it purchased a priority review voucher (PRV) in the current reporting period, and Medicines Development for Global Health (MDGH) confirms it was the seller.
-
EnGeneIC Wins Innovation Award from Australian Financial Review
8/9/2019
Named Most Innovative Healthcare Company of 2019 for its Nanocell Platform for Targeted Cyto-Immunotherapy in Cancer Treatment
-
Key Family 2 Patent Granted in Europe for RECCE® Antibiotics
8/8/2019
Recce Pharmaceuticals Limited announced the European Patent Office has granted its patent applications for wholly owned RECCE® antibiotics, including lead compound RECCE® 327 furthering marketing/manufacturing monopolies and expanding clinical indications.
-
Propanc Biopharma Completes Development of Bio-analytical Assay Method to Quantify PRP’s Active Ingredients in Preparation for First-In-Human Study
8/8/2019
Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today it has developed a method to quantify the active ingredients of Propanc’s lead product candidate, PRP, in preparation for the company’s First-In-Human (“FIH”) study, planned for early 2020.
-
Global Diagnostics Australia Incorporates Artificial Intelligence Into Its Radiology Applications
8/8/2019
Partnering with Aidoc to identify and prioritize patients with time-sensitive medical conditions
-
SpeeDx Pty. Ltd. Raises $15 Million From U.S. Investment Partnership
8/5/2019
SpeeDx Pty. Ltd., the developer of transformative new molecular diagnostic solutions, today announced it had raised up to US $10 million in additional equity investment from US-based Northpond Ventures
-
New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients
8/5/2019
Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and continuous treatment with long-lasting effect.
-
Chemist Warehouse And Smile Direct Club Team Up To Offer Customers A Straighter, More Affordable Smile
8/4/2019
SmileShop in-store pilot offers Chemist Warehouse customers increased access to safe and convenient teeth straightening solutions [04-August-2019] SYDNEY , Aug. 4, 2019 /PRNewswire/ -- Chemist Warehouse today announced its partnership with SmileDirectClub , the US-based teledentistry pioneer, to expand access to affordable and convenient orthodontic clear aligner the
-
BioSpace Global Roundup, August 1
8/1/2019
Companies from across the globe share business and pipeline updates. -
Recce to Give Opening R&D Address at 2019 World Antibiotic Resistance Congress
8/1/2019
Dr John Prendergast will showcase the potential of New Synthetic Antibiotics
-
Botanix receives commitments for A$40m in US-led institutional placement and announces appointment of key US management executives
8/1/2019
Clinical stage cannabinoid company Botanix Pharmaceuticals Limited is pleased to announce the receipt of firm commitments in respect of a A$40m placement led by specialist US-based biotech investment funds and leading US institutional investors, as well as the appointment of two new experienced dermatology executives.
-
Botanix Receives Commitments for A$40m in US-Led Institutional Placement and Announces Appointment of Key US Management Executives
8/1/2019
Botanix Pharmaceuticals Limited is pleased to announce the receipt of firm commitments in respect of a A$40m placement led by specialist US-based biotech investment funds and leading US institutional investors, as well as the appointment of two new experienced dermatology executives.
-
CannPal Commences Phase 2 Pilot Study for Cannabis-Derived Osteoarthritis Drug for Dogs
7/31/2019
Animal health company CannPal Animal Therapeutics Limited is pleased to announce the commencement of a Phase 2A pilot dose determination study for the Company's lead drug candidate, CPAT-01, in development for pain and inflammation control in dogs.
-
ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report
7/31/2019
Benitec Biopharma, a clinical-stage biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference platform combining RNA interference with gene therapy, announced its Appendix 4C for the quarter ending 31 July 2019.